Navigation Links
They Call It PMS Because Mad Cow Disease Was Already Taken

Premenstrual syndrome is an endocrine disorder characterized by nervous irritability, abnormal sensation in breasts, abdominal pain, thirst, headache and pelvic congestion.

For the first time, low dose oral contraceptive with a unique progestin and dosing regimen has been found effective in treating symptoms of premenstrual dysphoric disorder// (PMDD), the most severe form of premenstrual syndrome.

PMDD is characterized by cyclical mood, behavioral and physical symptoms that can be debilitating in some women. The cause of PMDD is unknown, although changes in steroid hormone levels have been held responsible for symptom production. On the same basis, hormones can be given to suppress ovarian activity thereby preventing the symptoms in these women.

A multi-center, double-blind, randomized clinical trial was conducted involving 450 women with symptoms of PMDD. The participants were given either the oral contraceptive or a placebo. Women who were given the oral contraceptive had significantly greater improvement (48.4 percent compared to 36.1 percent of women on placebo) in productivity, enjoyment of hobbies, social activities, and interpersonal relationships, and experienced greater symptom reduction. Forty-four women from both groups withdrew from the study due to adverse effects such as nausea and intermenstrual bleeding.

The low dose oral contraceptive contains drospirenone, a new progestin, and ethinyl estradiol. It was administered for 24 days followed by four days of inactive pills. The new regimen was designed for greater ovarian suppression and a more stable hormonal environment. The women were evaluated over the course of two menstrual cycles.

The analysis of the results has proved that the oral contraceptive method is effective in reducing symptoms associated with the PMS. For women who are seeking contraception in addition to control of PMDD, this would be more efficient because they could take just on e treatment.


'"/>




Related medicine news :

1. More Britons Take To Alcohol Because Of Stress
2. Do Women Die In Childbirth Because It Is More Preferable?
3. No Kidding, Children Obese Because of Overeating
4. Your Kids may Not Be Fat Because of too Much TV or Video Games
5. TB Cases, Deaths Decline in Yemen Because of Awareness Programs
6. Number of TB Cases in Malta Increasing in Part Because of Immigration
7. Junior Doctors Facing More Misery Because of Contract Deadlock: BMA
8. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
9. Vitamins-The answer to Heart Disease?
10. Link between Constipation and Parkinsons Disease
11. Levels Of Blood Proteins May Help Heart Disease Care
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are ... saves lives. However, if one isn’t accessible in certain locations, the risk of ... I came up with this idea," said an inventor from Ridgecrest, Calif. , ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from Sonora, ... Educational Leadership and Administration at St. Thomas University in Miami, Florida, was selected ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... emergency rooms is celebrating the one year anniversary of its Houston-Fallbrook facility. ... said Dr. Otinwa, Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It ...
(Date:9/22/2017)... Diego, CA (PRWEB) , ... September 22, 2017 ... ... offer groceries, wearable, and more products at customers’ doorstep. According to Smart Mart, ... Smart Mart has stated to offer wearable, and customers can find clothing at ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , ... wrong, run afoul of The Quality System Regulation (§820.250), and Devicemakers find themselves ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
(Date:9/5/2017)... Sept. 5, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral ... concluded its meeting with the U.S. Food and Drug ... formulation. At the ... pathway for submission of ORMD-0801, would be a Biologics ...
(Date:8/29/2017)... 2017 ivWatch, LLC, the leading provider of continuous monitoring ... has been awarded an Innovative Technology contract from Vizient, Inc., the ... ... in the early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ...
Breaking Medicine Technology: